Intraday surge! Three major sectors, a wave of limit-up hits!

The A-share market today (March 27) opened lower but closed higher, with major indices collectively rising during the session, turning fully positive. On the market, the three major sectors of non-ferrous metals, pharmaceuticals and biotechnology, and basic chemicals saw a surge of stocks hitting the daily limit.

The Hong Kong stock market experienced overall narrow fluctuations this morning, with China Longgong surging over 20% during the session, becoming one of the best-performing stocks in the Hong Kong market this morning.

A-share three major sectors see a surge of stocks hitting the daily limit

The A-share market rose overall this morning, with major indices increasing to varying degrees. As of the morning close, the Shanghai Composite Index rose by 0.26%, the Shenzhen Component Index rose by 0.93%, the ChiNext Index rose by 0.83%, and the STAR Market Comprehensive Index rose by 1.08%.

Specifically, by sector and track, according to Shenwan’s first-level industry classification, the non-ferrous metals sector led the gains, with the sector rising by 2.6%. In terms of individual stocks, Shenzhen New Star, Haixing Co., Rongjie Co., Yunnan Zinc Industry, Shengxin Lithium Energy, and Jinhui Co. saw multiple stocks hit the daily limit.

The pharmaceuticals and biotechnology sector also performed strongly, with stocks like Rejing Biotech, Yinos, Shutaishen, and Huana Pharmaceutical seeing gains exceeding 10%. Multiple stocks such as Lianhuan Pharmaceutical, Wanbangde, Zhaoyan New Drug, Jidan Bio, Meinuohua, and Kanghong Pharmaceutical hit the daily limit.

The basic chemicals sector also saw significant gains, with stocks in this sector experiencing a surge of stocks hitting the daily limit. Among them, Ketuobiotech, Shandong Haifa, and Chitianhua saw over ten stocks hit the daily limit.

The beauty and personal care, agriculture, forestry, animal husbandry, and fishery sectors also rose.

New stock Puan Medical sees a peak increase of over 170% during the session

Today, a new stock was listed on the A-share market, Puan Medical, which saw its price increase by over 170% during the morning session.

According to the prospectus, Puan Medical specializes in the research, production, and sales of diabetes care, general drug infusion, and minimally invasive medical devices, targeting chronic disease treatments such as diabetes, tumors, and gastrointestinal diseases. Relying on the company’s continuous R&D upgrades and ongoing improvements in safety, minimally invasive techniques, and comfort, it develops a rich matrix of chronic disease treatment products to provide high-quality and diverse medical devices for home use and professional institutions across various scenarios.

The prospectus states that according to QYResearch data, global sales of insulin pen needles from 2022 to 2024 are projected to be 8.81 billion, 9.43 billion, and 9.97 billion, respectively. During the same period, the company’s sales of insulin pen needles are projected to be 662 million, 753 million, and 1.175 billion, with market shares of 7.52%, 7.98%, and 11.78%, respectively, indicating a steady increase in global market share.

Hong Kong stocks experience overall narrow fluctuations, China Longgong surges over 20%

The Hong Kong stock market experienced overall narrow fluctuations this morning.

Among the Hang Seng Index constituents, stocks like CSPC Pharmaceutical Group, Haidilao, and Innovent Biologics led the gains this morning, each rising over 5% at one point during the session.

Among the stocks eligible for Stock Connect, China Longgong surged, with its price increasing over 20% during the session.

China Longgong’s performance announcement for the full year of 2025, released last night, showed that the group’s performance continued to grow during the reporting period, achieving total operating revenue of 11.215 billion yuan, a year-on-year increase of 9.81%. The group’s product structure is primarily composed of loaders and forklifts, with loaders remaining the group’s flagship product and main source of profit. Benefiting from a substantial increase in sales of electric loaders and new export products, the sales proportion of loaders rose by 1.91 percentage points year-on-year to 43.14%. The sales proportion of forklifts during this period was 30.82%, a decrease of 5.59 percentage points compared to the same period in 2024, mainly due to a year-on-year decline in sales. The domestic demand for excavators showed structural recovery, and overseas market demand continued to be released, with its sales proportion increasing by 4.73 percentage points compared to the same period in 2024 to 15.07%.

China Longgong indicated that the group’s efforts to expand overseas markets have been significant, achieving overseas revenue of 3.806 billion yuan, a year-on-year increase of 19.32%, setting a new historical performance record. During the reporting period, the group’s overall gross profit margin was 21.37%, an increase of 1.81 percentage points compared to 19.56% in the same period of 2024.

China Longgong achieved a net profit of 1.301 billion yuan for the full year of 2025, a year-on-year increase of 27.69%. The increase in net profit was mainly due to steady growth in domestic and international sales, especially the increasing contribution of export business to profitability. Additionally, the group continues to develop new products, with high-value-added new products becoming the main contributors to profit growth. Furthermore, efforts to improve quality, control costs, and increase efficiency have shown significant results, further enhancing the overall gross profit margin of products.

Proofread by: Yang Shuxin